Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Cervical Spine Bone Graft Gains FDA Go-Ahead

This article was originally published in The Gray Sheet

Executive Summary

Cerapedics' i-Factor peptide-enhanced bone graft will be used to treat degenerative cervical disc disease, the first bone graft product PMA-approved for that indication, the company says.


Related Content

High Court Won’t Hear InFuse Off-Label Preemption Case
Wright Brings New Biologic To U.S. Ortho Space With Augment Approval
New Product Briefs


Related Companies